These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 29539583

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.
    Hjortnaes J, Goettsch C, Hutcheson JD, Camci-Unal G, Lax L, Scherer K, Body S, Schoen FJ, Kluin J, Khademhosseini A, Aikawa E.
    J Mol Cell Cardiol; 2016 May; 94():13-20. PubMed ID: 26996755
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating Inflammation, Fibrosis, and Calcification.
    Choi B, Kim EY, Kim JE, Oh S, Park SO, Kim SM, Choi H, Song JK, Chang EJ.
    Cells; 2021 Jan 01; 10(1):. PubMed ID: 33401457
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Matrix metalloproteinase inhibitor, doxycycline and progression of calcific aortic valve disease in hyperlipidemic mice.
    Jung JJ, Razavian M, Kim HY, Ye Y, Golestani R, Toczek J, Zhang J, Sadeghi MM.
    Sci Rep; 2016 Sep 13; 6():32659. PubMed ID: 27619752
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. NFκB (Nuclear Factor κ-Light-Chain Enhancer of Activated B Cells) Activity Regulates Cell-Type-Specific and Context-Specific Susceptibility to Calcification in the Aortic Valve.
    Gee T, Farrar E, Wang Y, Wu B, Hsu K, Zhou B, Butcher J.
    Arterioscler Thromb Vasc Biol; 2020 Mar 13; 40(3):638-655. PubMed ID: 31893948
    [Abstract] [Full Text] [Related]

  • 30. Role of Runx2 in Calcific Aortic Valve Disease in Mouse Models.
    Dharmarajan S, Speer MY, Pierce K, Lally J, Leaf EM, Lin ME, Scatena M, Giachelli CM.
    Front Cardiovasc Med; 2021 Mar 13; 8():687210. PubMed ID: 34778386
    [Abstract] [Full Text] [Related]

  • 31. In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR-/-ApoB100/100 mice.
    Blanco F, Heinonen SE, Gurzeler E, Berglund LM, Dutius Andersson AM, Kotova O, Jönsson-Rylander AC, Ylä-Herttuala S, Gomez MF.
    Diab Vasc Dis Res; 2018 Jul 13; 15(4):302-313. PubMed ID: 29499628
    [Abstract] [Full Text] [Related]

  • 32. Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.
    Jung JJ, Razavian M, Challa AA, Nie L, Golestani R, Zhang J, Ye Y, Russell KS, Robinson SP, Heistad DD, Sadeghi MM.
    J Nucl Med; 2015 Jun 13; 56(6):933-8. PubMed ID: 25908827
    [Abstract] [Full Text] [Related]

  • 33. RAGE deficiency alleviates aortic valve calcification in ApoE-/- mice via the inhibition of endoplasmic reticulum stress.
    Wang B, Cai Z, Liu B, Liu Z, Zhou X, Dong N, Li F.
    Biochim Biophys Acta Mol Basis Dis; 2017 Mar 13; 1863(3):781-792. PubMed ID: 28024939
    [Abstract] [Full Text] [Related]

  • 34. End stage renal disease-induced hypercalcemia may promote aortic valve calcification via Annexin VI enrichment of valve interstitial cell derived-matrix vesicles.
    Cui L, Rashdan NA, Zhu D, Milne EM, Ajuh P, Milne G, Helfrich MH, Lim K, Prasad S, Lerman DA, Vesey AT, Dweck MR, Jenkins WS, Newby DE, Farquharson C, Macrae VE.
    J Cell Physiol; 2017 Nov 13; 232(11):2985-2995. PubMed ID: 28369848
    [Abstract] [Full Text] [Related]

  • 35. Aldo-keto reductase family 1 member B induces aortic valve calcification by activating hippo signaling in valvular interstitial cells.
    Gao C, Hu W, Liu F, Zeng Z, Zhu Q, Fan J, Chen J, Cheng S, Yu K, Qian Y, Ren T, Zhao J, Liu X, Wang J.
    J Mol Cell Cardiol; 2021 Jan 13; 150():54-64. PubMed ID: 33045251
    [Abstract] [Full Text] [Related]

  • 36. Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus.
    Mosch J, Gleissner CA, Body S, Aikawa E.
    Histol Histopathol; 2017 Mar 13; 32(3):293-306. PubMed ID: 27353274
    [Abstract] [Full Text] [Related]

  • 37. Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE-/- mice.
    Rattazzi M, Faggin E, Bertacco E, Nardin C, Pagliani L, Plebani M, Cinetto F, Guidolin D, Puato M, Pauletto P.
    Cardiovasc Ther; 2018 Aug 13; 36(4):e12438. PubMed ID: 29847020
    [Abstract] [Full Text] [Related]

  • 38. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia.
    Heinonen SE, Leppänen P, Kholová I, Lumivuori H, Häkkinen SK, Bosch F, Laakso M, Ylä-Herttuala S.
    Circ Res; 2007 Nov 09; 101(10):1058-67. PubMed ID: 17872464
    [Abstract] [Full Text] [Related]

  • 39. Association between shear stress and platelet-derived transforming growth factor-β1 release and activation in animal models of aortic valve stenosis.
    Wang W, Vootukuri S, Meyer A, Ahamed J, Coller BS.
    Arterioscler Thromb Vasc Biol; 2014 Sep 09; 34(9):1924-32. PubMed ID: 24903096
    [Abstract] [Full Text] [Related]

  • 40. Diabetes mellitus accelerates cartilaginous metaplasia and calcification in atherosclerotic vessels of LDLr mutant mice.
    Nguyen N, Naik V, Speer MY.
    Cardiovasc Pathol; 2013 Sep 09; 22(2):167-75. PubMed ID: 22818582
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.